Physician profile
Matthew Hansen
NPI 1649751934
$1,471.07
in general payments reported to CMS, 2019-2025
12 companies · $828 in 2025
The $828 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $31.25 · 2022: $46.58 · 2023: $237 · 2024: $327 · 2025: $828.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,289 · Travel and Lodging: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,289.24 |
| Travel and Lodging | $104.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $624.56 | 2025 | Senza, Vyrsa V1 |
| Nevro Corp. | $428.19 | 2022-2024 | Senza |
| Si-Bone, INC. | $89.37 | 2024-2025 | |
| Nalu Medical, INC. | $69.03 | 2023 | Nalu Neurostimulation System |
| Boston Scientific Corporation | $49.33 | 2025 | General - Pain Management |
| Saluda Medical Americas, INC. | $40.84 | 2025 | Evoke |
| Abbvie INC. | $38.72 | 2024-2025 | |
| Pfizer INC. | $34.88 | 2024 | |
| Davol INC. | $31.25 | 2021 | |
| Collegium Pharmaceutical, INC. | $22.85 | 2025 | Belbuca |
| Bioventus LLC | $22.59 | 2025 | Gelsyn-3 |
| Averitas Pharma INC. | $19.46 | 2024 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.